SMILES string
[S]1(=O)(=O)C2N([C@H](C1(C)C)C(=O)OCOC(=O)[C@@H]3N4C(SC3(C)C)C(C4=O)NC(=O)[C@@H](N)c5ccccc5)C(=O)C2
InChI
1S/C25H30N4O9S2/c1-24(2)17(29-20(32)16(21(29)39-24)27-19(31)15(26)12-8-6-5-7-9-12)22(33)37-11-38-23(34)18-25(3,4)40(35,36)14-10-13(30)28(14)18/h5-9,14-18,21H,10-11,26H2,1-4H3,(H,27,31)/t14?,15-,16?,17-,18-,21?/m0/s1
InChI key
OPYGFNJSCUDTBT-CUUJHUNTSA-N
grade
pharmaceutical primary standard
API family
sultamicillin
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
存储类别
11 - Combustible Solids
wgk
WGK 3
法规信息
涉药品监管产品
此项目有
Efficacy and safety of sultamicillin (750 mg bid) compared with amoxycillin/clavulanate (625 mg tid) in patients with umcomplicated urinary tract infections.
Schutz W.
International Journal of Antimicrobial Agents, 6, S55-S59 (1996)
Ralf Smeets et al.
The International journal of oral & maxillofacial implants, 32(6), 1338–1345-1338–1345 (2017-10-14)
To test the antimicrobial properties, surface topography, reaction of surrounding tissue (biocompatibility), and osseointegration of ultrathin implant surfaces containing polysiloxane and nanoscaled silver particles. Implants with polysiloxane coating and nanoscaled silver particles (Ag/SiO Roughness parameters did not differ between all
Efficacy and safety of Sultamicillin (Ampicillin/Sulbactan) and Amoxicillin/Clavulanic Acid in the treatment of upper respiratory tract infections in adults: an open-label, multicentric, randomized trial.
Ferreira J B, et al.
Revista Brasileira de Otorrinolaringologia, 72(1), 104-111 (2006)
H A Friedel et al.
Drugs, 37(4), 491-522 (1989-04-01)
Sultamicillin is the tosylate salt of the double ester of sulbactam plus ampicillin. Sulbactam is a semisynthetic beta-lactamase inhibitor which, in combination with ampicillin, extends the antibacterial activity of the latter to include some beta-lactamase-producing strains of bacteria that would
HPLC for in-process control in the production of sultamicillin.
Laviana L, et al.
Journal of Pharmaceutical and Biomedical Analysis, 31(2), 321-328 (2003)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持